[CH3:1][O:2][C:3]([C:5]1[CH:10]=[N:9][C:8](N)=[C:7]([C:12]2[CH:17]=[CH:16][C:15]([F:18])=[CH:14][CH:13]=2)[N:6]=1)=[O:4].N(OCCC(C)C)=O.C[Si](C)(C)[Br:29].C(=O)(O)[O-].[Na+]>BrCBr>[CH3:1][O:2][C:3]([C:5]1[CH:10]=[N:9][C:8]([Br:29])=[C:7]([C:12]2[CH:17]=[CH:16][C:15]([F:18])=[CH:14][CH:13]=2)[N:6]=1)=[O:4]To a suspension of 1.26 g 5-amino-6-(4-fluoro-phenyl)-pyrazine-2-carboxylic acid methyl ester in 25.0 ml dibromomethane was added 0.85 ml isoamyl nitrite. To the resulting suspension was added during 30 minutes a solution of 0.82 ml trimethyl bromosilane in 5 ml dibromomethane at room temperature. The mixture was stirred at room temperature for 2 hours. To the resulting turbid solution was added 10% aqueous sodium bicarbonate, the phases were separated and the organic layer was dried over magnesium sulfate, evaporated and purified by chromatography on silica gel using a gradient of heptane to 10% ethyl acetate in heptane to yield 0.81 g of the title compound as white crystals. MS (ISP) (M+H+)=311.1 and 313.0.